A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Austin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Embolic Protection Devices Market Size and Growth Analysis: According to SNS Insider, the global Embolic Protection Devices Market was valued at USD 656.60 ...
CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Please provide your email address to receive an email when new articles are posted on . Adults who underwent transcatheter aortic valve replacement with a cerebral protection system experienced fewer ...
Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...
CHICAGO, IL—A large-scale, randomized trial testing routine cerebral embolic protection during TAVI has once again failed to show the device reduces the risk of stroke. The two trials, which in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results